|Bid||0.00 x 4000|
|Ask||0.00 x 3200|
|Day's range||15.52 - 16.33|
|52-week range||13.05 - 23.25|
|Beta (5Y monthly)||0.99|
|PE ratio (TTM)||17.47|
|Earnings date||02 Nov 2022 - 07 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||07 Oct 2008|
|1y target est||22.11|
CHICAGO, September 19, 2022--Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) will host a virtual Investor Day on Wednesday, September 28, 2022 at 12:00 p.m. (Eastern). The event will include presentations made by members of the executive management team followed by a question-and-answer session. Participants may access the virtual conference by registering with our webcast registration or dial-in registration (for Q&A) links. Presentation slides will be posted on the day of the event, at ap
CHICAGO, September 14, 2022--Veradigm®, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), and Vytalize Health, a new kind of Medicare ACO focused on helping primary care doctors manage their Medicare patients, announced today a new agreement for Vytalize Health to integrate its solutions and services directly into the Practice Fusion EHR, a Veradigm Network solution.
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.